Functional intestinal microbiome, new frontiers in prebiotic design

International Journal of Food Microbiology

Volumn 140, Issue 2-3, 2010, Pages 93-101

  Candela, Marco ^a   Maccaferri, Simone ^a   Turroni, Silvia ^a   Carnevali, Paola ^b   Brigidi, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Barilla GR Flli SpA   (Italy)

Author keywords

Functional genomics; Intestinal microbiota; Microbiome; Prebiotics

Indexed keywords

PREBIOTIC AGENT;

ADAPTATION; BACTERIAL GENOME; CEREAL; DIET; DISEASE ASSOCIATION; DOUGH; FERMENTATION TECHNIQUE; FUNCTIONAL GENOMICS; GENE SEQUENCE; HUMAN; INTESTINE FLORA; METAGENOME; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL METABOLISM; MICROBIOME; NONHUMAN; NUTRITIONAL STATUS; ORGANISMS BY MUTUAL INTERACTION; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; BACTERIA; GENETICS; INTESTINE; METABOLISM; MICROBIOLOGY;

ANIMALS; BACTERIA; HUMANS; INTESTINES; METAGENOME; PREBIOTICS;

BACTERIA (MICROORGANISMS);

EID: 77953123228     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.04.017     Document Type: Review

References (81)

1. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Nat. Acad. Sci. USA 2004, 101:15718-15723.
2. Bäckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
3. Ballongue J., Schumann C., Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand. J. Gastroenterol. 1997, 222:41-44.
4. Boehm G., Lidestri M., Casetta P., Jelinek J., Negretti F., Stahl B., Marini A. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of fecal bifidobacteria in preterm infants. Arch. Dis. Child. 2002, 86:F178-F181.
5. Bouhnik Y., Flourié B., D'Agay-Abensour L., Pochart P., Gramet G., Duran M., Rambaud J.C. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J. Nutr. 1997, 127:444-448.
6. Cani P.D., Lecourt E., Dewulf E.M., Sohet F.M., Pachikian B.D., Naslain D., De Backer F., Neyrinck A.M., Delzenne N.M. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 2009, 90:1236-1243.
7. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D.M., Muccioli G.G., Delzenne N.M. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
8. Cherbut C. Inulin and oligofructose in the dietary fibre concept. Br. J. Nutr. 2002, 87(Suppl 2):s159-s162.
9. Davis C.D., Milner J.A. Gastrointestinal microflora, food components and colon cancer prevention. The Journal of Nutritional Biochemistry 2009, 20:743-752.
10. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., Lobley G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 2007, 73:1073-1078.
11. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
12. Flint H.J., Duncan S.H., Scott K.P., Louis P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ. Microbiol. 2007, 9:1101-1111.
13. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Nat. Acad. Sci. USA 2007, 104:13780-13785.
14. Gänzle M.G., Zhang C., Monang B.S., Lee V., Schwab C. Novel metabolites from cereal-associated Lactobacilli - novel functionalities for cereal products?. Food Microbiol. 2009, 26:712-719.
15. Garrett W.S., Gordon J.I., Glimcher L.H. Homeostasis and inflammation in the intestine. Cell 2010, 140:859-870.
16. Gibson G.R., Beatty E.R., Wang X., Cummings J.H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995, 108:975-982.
17. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995, 125:1401-1412.
18. Gibson G.R., Angus F. Leatherhead Ingredients Handbook 2000, Prebiotics and Probiotics Leatherhead Food Research Association, Leatherhead, UK.
19. Gibson G.R., Probert H.M., Loo J.V., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17:259-275.
20. Gibson G.R. Prebiotics as gut microflora management tools. J. Clin. Gastroenterol. 2008, 42(Suppl 2):S75-S79.
21. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
22. Gomez, E., Tuohy, K.M., Gibson, G.R., Klinder, A., Costabile, A., 2009. In vitro evaluation of the fermentation properties and potential prebiotic activity of Agave fructans. Journal of Applied Microbiology. 2009 Nov 4. [Electronic publication].
23. Harmsen H.J., Raangs G.C., Franks A., Wildeboer-Veloo A.C., Welling G.W. The effect of the prebiotic inulin and the probiotic Bifidobacterium longum on the fecal microflora of healthy volunteers measured by FISH and DGGE. Microbial Ecology in Health and Disease 2002, 14:212-220.
24. Hope M.E., Hold G.L., Kain R., El-Omar E.M. Sporadic colorectal cancer-role of the commensal microbiota. FEMS Microbiol. Lett. 2005, 244:1-7.
25. Hopkins M.J., Cummings J.H., Macfarlane G.T. Inter-species differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbohydrate sources. J. Appl. Bacteriol. 1998, 85:381-386.
26. Ito M., Kimura M., Deguchi Y., Miyamori-Watabe A., Yajima T., Kan T. Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism. J. Nutr. Sci. Vitaminol. 1993, 39:279-288.
27. Jaskari J., Konbula P., Siitonen A., Jousimes-Somen H., Matilla-Sandholm T., Poutamen K. Oat beta-glucan and xylan hydrolyzates as selective substrates for Bifidobacterium and Lactobacillus strains. Appl. Microbiol. Biotechnol. 1998, 49:175-181.
28. Jia W., Li H., Zhao L., Nicholson J.K. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 2008, 7:123-129.
29. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004, 32. D277-280.
30. Kaneko T., Kohmoto T., Kikuchi H., Shiota M., Iino H., Mitsuoka T. Effects of isomaltooligosaccharides with different degrees of polymerization on human fecal bifidobacteria. Biosci. Biotechnol., Biochem. 1994, 58:2288-2290.
31. Kaneko T., Yokoyama A., Suzuki M. Digestibility characteristics of isomaltooligosaccharides in comparison with several saccharides using the rat jejunum loop method. Biosci. Biotechnol., Biochem. 1995, 59:1190-1194.
32. Katina K., Maina N.H., Juvonen R., Flander L., Johansson L., Virkki L., Tenkanen M., Laitila A. In situ production and analysis of Weissella confusa dextran in wheat sourdough. Food Microbiol. 2009, 26:734-743.
33. Kedia G., Vázquez J.A., Charalampopoulos D., Pandiella S.S. In vitro fermentation of oat bran obtained by debranning with a mixed culture of human fecal bacteria. Current Microbiology 2009, 58:338-342.
34. Keenan T.W., Patton S. Nature of milk lipid globule membrane. Handbook of Milk Composition 1995, 5-50. Academic Press Inc., New York. R.G. Jensen (Ed.).
35. Kitov P.I., Sadowska J.M., Mulvey G., Armstrong G.D., Ling H., Pannu N.S., Read R.J., Bundle D.R. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 2000, 403:669-672.
36. Kleerebezem M., Vaughan E.E. Probiotic and gut Lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu. Rev. Microbiol. 2009, 63:269-290.
37. Kohmoto T., Fukui F., Takaku H., Machida Y., Arai M., Mitsuoka T. Effect of isomalto-oligosaccharides on human fecal flora. Bifidobacteria Microflora 1988, 7:61-69.
38. Kohmoto T., Fukui F., Takaku H., Mitsuoka T. Dose-response test of isomaltooligosaccharides for increasing fecal bifidobacteria. Agric. Biol. Chem. 1991, 55:2157-2159.
39. Korakli M., Gänzle M.G., Vogel R.F. Metabolism by bifidobacteria and lactic acid bacteria of polysaccharides from wheat and rye, and exopolysaccharides produced by Lactobacillus sanfranciscensis. J. Appl. Microbiol. 2002, 92:958-965.
40. Kumemura M., Hashimoto F., Fujii C., Matsuo K., Kimura H., Miyazoe R., Okamatsu H., Inokuchi T., Ito H., Oizumi K., Oku T. Effects of administration of 4G-beta-D-galactosylsucrose on fecal microflora putrefactive products, short chain fatty acids, weight, moisture, and subjective sensation of defecation in the elderly with constipation. J. Clin. Biochem. Nutr. 1992, 13:199-210.
41. Laparra J.M., Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacological Research 2009, Electronic publication.
42. Ley R.E., Hamady M., Lozupone C., Turnbaugh P.J., Ramey R.R., Bircher J.S., Schlegel M.L., Tucker T.A., Schrenzel M.D., Knight R., Gordon J.I. Evolution of mammals and their gut microbes. Science 2008, 320:1647-1651.
43. Lomax A.R., Calder P.C. Prebiotics, immune function, infection and inflammation: a review of the evidence. Br. J. Nutr. 2009, 101:633-658.
44. Mahowald M.A., Rey F.E., Seedorf H., Turnbaugh P.J., Fulton R.S., Wollam A., Shah N., Wang C., Magrini V., Wilson R.K., Cantarel B.L., Coutinho P.M., Henrissat B., Crock L.W., Russell A., Verberkmoes N.C., Hettich R.L., Gordon J.I. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc. Nat. Acad. Sci. USA 2009, 106:5859-5864.
45. Mäkeläinen H., Hasselwander O., Rautonen N., Ouwehand A.C. Panose, a new prebiotic candidate. Lett. Appl. Microbiol. 2009, 49:666-672.
46. Martin F.P., Dumas M.E., Wang Y., Legido-Quigley C., Yap I.K., Tang H., Zirah S., Murphy G.M., Cloarec O., Lindon J.C., Sprenger N., Fay L.B., Kochhar S., van Bladeren P., Holmes E., Nicholson J.K. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 2007, 3:112.
47. McKenna P., Hoffmann C., Minkah N., Aye P.P., Lackner A., Liu Z., Lozupone C.A., Hamady M., Knight R., Bushman F.D. The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog. 2008, 4:e20.
48. Moro G., Minoli I., Mosca M., Fanaro S., Jelinek J., Stahl B., Boehm G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 2002, 34:291-295.
49. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.
50. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Reports 2006, 7:688-693.
51. Ohkusa T., Ozaki Y., Sato C., Mikuni K., Ikeda H. Long-term ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora. Digestion 1995, 56:415-420.
52. Okazaki M., Fujikawa S., Matsumoto N. Effects of xylooligosaccharide on growth of bifidobacteria. J. Jpn. Soc. Nutr. Food Sci. 1990, 43:395-401.
53. Parnell J.A., Reimer R.A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 2009, 89:1751-1759.
54. Pédron T., Sansonetti P. Commensals, bacterial pathogens and intestinal inflammation: an intriguing ménage à trois. Cell Host Microbe 2008, 3:344-347.
55. Peterson D.A., Frank D.N., Pace N.R., Gordon J.I. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008, 3:417-427.
56. Pouillart, P.R., Dépeint, F., Abdelnour, A., Deremaux, L., Vincent, O., Mazière, J.C., Madec, J.Y., Chatelain, D., Younes, H., Wils, D., Saniez, M.H., Dupas, J.L., 2009. Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets. Inflammatory Bowel Disease, 2009 Dec 8. [Electronic publication].
57. Poutanen K., Flander L., Katina K. Sourdough and cereal fermentation in a nutritional perspective. Food Microbiol. 2009, 26:693-699.
58. Rajilić-Stojanović M., Smidt H., de Vos W.M. Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 2007, 9:2125-2136.
59. Rao V. The prebiotic properties of oligofructose at low intake levels. Nutr. Res. 2001, 21:843-848.
60. Rawls J.F. Enteric infection and inflammation alter gut microbial ecology. Cell Host Microbe 2007, 2:73-74.
61. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9:313-323.
62. Rowland I.R., Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human fecal microflora. J. Appl. Bacteriol. 1993, 74:667-674.
63. Sansonetti P.J., Medzhitov R. Learning tolerance while fighting ignorance. Cell 2009, 138:416-420.
64. Sherman P.M., Cabana M., Gibson G.R., Koletzko B.V., Neu J., Veereman-Wauters G., Ziegler E.E., Walker W.A. Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008. J. Pediatr. 2009, 155:S61-S70.
65. Shoaf K., Mulvey G.L., Armstrong G.D., Hutkins R.W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect. Immun. 2006, 74:6920-6928.
66. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.J., Blugeon S., Bridonneau C., Furet J.P., Corthier G., Grangette C., Vasquez N., Pochart P., Trugnan G., Thomas G., Blottière H.M., Doré J., Marteau P., Seksik P., Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Nat. Acad. Sci. USA 2008, 105:16731-16736.
67. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., Chaffron S., Macpherson A.J., Buer J., Parkhill J., Dougan G., von Mering C., Hardt W.D. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007, 5:2177-2189.
68. Tatusov R.L., Natale D.A., Garkavtsev I.V., Tatusova T.A., Shankavaram U.T., Rao B.S., Kiryutin B., Galperin M.Y., Fedorova N.D., Koonin E.V. The COG database: new developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 2001, 29:22-28.
69. Terada A., Hara H., Kato S., Kimura T., Fujimori I., Hara K., Maruyama T., Mitsuoka T. Effect of lactosucrose (4G-beta-D-galactosylsucrose) on fecal flora and fecal putrefactive products of cats. J. Vet. Med. Sci. 1993, 55:291-295.
70. Tieking M., Korakli M., Ehrmann M.A., Gänzle M.G., Vogel R.F. In situ production of exopolysaccharides during sourdough fermentation by cereal and intestinal isolates of lactic acid bacteria. Appl. Environ. Microbiol. 2003, 69:945-952.
71. Tieking M., Kühnl W., Gänzle M.G. Evidence for formation of heterooligosaccharides by Lactobacillus sanfranciscensis during growth in wheat sourdough. J. Agric. Food Chem. 2005, 53:2456-2461.
72. Tomomatsu H. Health effects of oligosaccharides. Food Technol. 1994, 48:61-65.
73. Tuohy K.M., Ziemer C.J., Klinder A., Knöbel Y., Pool-Zobel B.L., Gibson G.R. A human volunteer study to determine the prebiotic effects of lactulose powder on human colonic microbiota. Microbia. Ecol. Health Dis. 2002, 14:165-173.
74. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449:804-810.
75. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., Egholm M., Henrissat B., Heath A.C., Knight R., Gordon J.I. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
76. Ventura M., O'Flaherty S., Claesson M.J., Turroni F., Klaenhammer T.R., van Sinderen D., O'Toole P.W. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat. Rev. Microbiol. 2009, 7:61-71.
77. Wichienchot S., Prasertsan P., Hongpattarakere T., Gibson G.R., Rastall R.A. In vitro three-stage continuous fermentation of gluco-oligosaccharides produced by Gluconobacter oxydans NCIMB 4943 by the human colonic microflora. Curr. Issues Intest. Microbiol. 2006, 7:13-18.
78. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., Hooper L.V., Gordon J.I. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076.
79. Xu J., Mahowald M.A., Ley R.E., Lozupone C.A., Hamady M., Martens E.C., Henrissat B., Coutinho P.M., Minx P., Latreille P., Cordum H., Van Brunt A., Kim K., Fulton R.S., Fulton L.A., Clifton S.W., Wilson R.K., Knight R.D., Gordon J.I. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 2007, 5:e156.
80. Zannini E., Garofalo C., Aquilanti L., Santarelli S., Silvestri G., Clementi F. Microbiological and technological characterization of sourdoughs destined for bread-making with barley flour. Food Microbiol. 2009, 26:744-753.
81. Zoetendal E.G., Rajilic-Stojanovic M., de Vos W.M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57:1605-1615.